Sector
PharmaceuticalsOpen
₹705Prev. Close
₹686.1Turnover(Lac.)
₹591.47Day's High
₹725Day's Low
₹68852 Week's High
₹794.552 Week's Low
₹306.2Book Value
₹220.47Face Value
₹5Mkt Cap (₹ Cr.)
1,440.45P/E
24.59EPS
27.82Divi. Yield
0.810 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
5 May 2023
12:00 AM
Dividend
Dividend Amount: 4
Record Date: 05 Sep, 2023
16 Aug 2023
12:00 AM
AGM
Announcement Date: 16 Aug, 2023
17 Aug 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 10.46 | 10.9 | 6.41 | 6.41 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 392.2 | 384.23 | 192.58 | 210.07 |
Net Worth | 402.66 | 395.13 | 198.99 | 216.48 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 630.96 | 513.08 | 465.93 | 427.6 | 328.85 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 630.96 | 513.08 | 465.93 | 427.6 | 328.85 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 13.47 | 9.97 | 6.71 | 8.74 | 2.49 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Vivek Dhariwal
Whole-time Director
Ashok Kumar Windlass
Managing Director
Hitesh Windlass
Joint Managing Director
Manoj Kumar Windlass
Executive Director
Pawan Kumar Sharma
Non-Exec & Non-Independent Dir
Prachi Jain Windlass
Non-Exec. & Independent Dir.
Srinivasan Venkataraman
Non-Exec. & Independent Dir.
Gaurav Gulati
Company Sec. & Compli. Officer
Ananta Narayan Panda
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Windlas Biotech Ltd
Summary
Windlas Biotech Ltd (formerly known as Windlas Biotech Private Limited) was incorporated in the year 2001. The Company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.The company has state-of-the-art manufacturing plant facilities located in Dehradun, Uttarakhand, India. It also has a sales force and distribution network spread across 14 states. The company market its own manufactured authentic nutraceutical, pharmaceutical and Ayurvedic products to serve the semi-urban and rural communities at affordable prices. Apart from this, the company has three distinct strategic business verticals (SBVs) mainly comprising of CDMO services and products; domestic trade generics and over-the-counter (OTC) brands; and exports.The company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (GMP) with a focus on improved safety, efficacy and cost. In addition to this, it sells its own branded products in the trade generics and OTC markets as well as export generic products to several countries. Moreover, the company has significant experience in developing and manufacturing generic fixed dose combinations. Its focus has currently been in launching new complex generic products in
Read More
What is the Windlas Biotech Ltd share price today?
The Windlas Biotech Ltd shares price on N/A is Rs.₹689 today.
What is the Market Cap of Windlas Biotech Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Windlas Biotech Ltd is ₹1440.03 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Windlas Biotech Ltd?
The PE and PB ratios of Windlas Biotech Ltd is 24.59 and 3.17 as of 22 Jul ‘24
What is the 52 Week High and Low of Windlas Biotech Ltd?
The 52-week high/low is the highest and lowest price at which a Windlas Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Windlas Biotech Ltd is ₹305.85 and ₹792.45 as of 22 Jul ‘24
What is the CAGR of Windlas Biotech Ltd?
Windlas Biotech Ltd's CAGR for 5 Years at N/I%, 3 Years at 18.92%, 1 Year at 107.05%, 6 Month at 41.34%, 3 Month at 23.23% and 1 Month at -2.22%.
What is the shareholding pattern of Windlas Biotech Ltd?
The shareholding pattern of Windlas Biotech Ltd is as follows:
Promoters - 62.51 %
Institutions - 11.94 %
Public - 25.55 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
